Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery.


Journal Article

Biomarkers for acute kidney injury (AKI) have been used to predict the progression of AKI, but a systematic comparison of the prognostic ability of each biomarker alone or in combination has not been performed. In order to assess this, we measured the concentration of 32 candidate biomarkers in the urine of 95 patients with AKIN stage 1 after cardiac surgery. Urine markers were divided into eight groups based on the putative pathophysiological mechanism they reflect. We then compared the ability of the markers alone or in combination to predict the primary outcome of worsening AKI or death (23 patients) and the secondary outcome of AKIN stage 3 or death (13 patients). IL-18 was the best predictor of both outcomes (AUC of 0.74 and 0.89). L-FABP (AUC of 0.67 and 0.85), NGAL (AUC of 0.72 and 0.83), and KIM-1 (AUC of 0.73 and 0.81) were also good predictors. Correlation between most of the markers was generally related to their predictive ability, but KIM-1 had a relatively weak correlation with other markers. The combination of IL-18 and KIM-1 had a very good predictive value with an AUC of 0.93 to predict AKIN 3 or death. Thus, a combination of IL-18 and KIM-1 would result in improved identification of high-risk patients for enrollment in clinical trials.

Full Text

Cited Authors

  • Arthur, JM; Hill, EG; Alge, JL; Lewis, EC; Neely, BA; Janech, MG; Tumlin, JA; Chawla, LS; Shaw, AD; SAKInet Investigators,

Published Date

  • February 2014

Published In

Volume / Issue

  • 85 / 2

Start / End Page

  • 431 - 438

PubMed ID

  • 24005224

Pubmed Central ID

  • 24005224

Electronic International Standard Serial Number (EISSN)

  • 1523-1755

Digital Object Identifier (DOI)

  • 10.1038/ki.2013.333


  • eng

Conference Location

  • United States